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Abstract
Diagnostic tests are of critical importance in health care and medical research. Motivated by the impact that
atypical and outlying test outcomes might have on the assessment of the discriminatory ability of a diagnostic test,
we develop a flexible and robust model for conducting inference about the covariate-specific receiver operating char-
acteristic (ROC) curve that safeguards against outlying test results while also accommodating for possible nonlinear
effects of the covariates. Specifically, we postulate a location-scale additive regression model for the test outcomes
in in both the diseased and nondiseased populations, combining additive cubic B-splines and M-estimation for the
regression function, while the residuals are estimated via a weighted empirical distribution function. The results of
the simulation study show that our approach successfully recovers the true covariate-specific ROC curve and cor-
responding area under the curve on a variety of conceivable test outcomes contamination scenarios. Our method
is applied to a dataset derived from a prostate cancer study where we seek to assess the ability of the Prostate
Health Index to discriminate between men with and without Gleason 7 or above prostate cancer, and if and how
such discriminatory capacity changes with age.
key words: Additive model; Covariate-adjustment; Diagnostic test; Outliers; Receiver operating charac-
teristic curve; M-estimation
1 INTRODUCTION
The evaluation of the performance of a medical test for screening and diagnosing disease is an important step
towards advancing health in individuals and communities. The major goal of a diagnostic test is to distinguish
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diseased from nondiseased individuals or, more generally, to distinguish between different disease stages. Before
the widespread use of a test, its ability to discriminate between the different states must be rigorously vetted.
Note that here we use the term ‘diagnostic test’ to broadly encompass any continuous classifier, which may
include a single biological marker or a composite score resulting from the combination of multiple biomarkers.
We further note that we will be assuming the existence of a so-called gold standard test, i.e., a perfect test
that correctly classifies all individuals as being diseased or nondiseased. Compared to the diagnosis made
by the gold standard test, the goal is to assess how well the candidate test, which is possibly less invasive
and/or costly, performs. The receiver operating characteristic (ROC) curve is the most popular graphical tool
used for evaluating the discriminatory ability of continuous-outcome tests. The ROC curve is a plot of the
false positive fraction (probability that a nondiseased subject tests positive) against the true positive fraction
(probability that a diseased subject tests positive) for all possible threshold values that can be used to convert
continuous test outcomes into binary ones. Further background on ROC curves is provided in Section 2.
It has been recognised that the performance of a test may be affected by covariates, such as age and/or
gender and, in such situations, ignoring covariate information might result in erroneous inferences about a
test’s accuracy. The full understanding of how covariates impact a test’s performance is thus of paramount
importance in order to determine the optimal and suboptimal populations, as defined by the covariate values,
in which to perform the tests. The covariate-specific or conditional ROC curve, which is an ROC curve that
conditions on a specific covariate value, arises as the natural tool to use in this context (Pepe 1998 and Pepe
2003, Chapter 6). Approaches to the estimation of the covariate-specific ROC curve can be broadly divided in
two categories (Pepe, 1998): (i) induced methodologies, our focus in this paper, that model the distribution
of test outcomes in the diseased and nondiseased populations separately and then compute the induced ROC
curve, and (ii) direct methodologies that assume a regression model for the ROC curve itself. A comparative
study of both methodologies can be found in Rodr´ıguez-A´lvarez et al. (2011b) and for a recent overview of
available methods we refer to Ina´cio and Rodr´ıguez-A´lvarez (2021).
Motivated by the fact that atypical/outlying test outcomes (due, for instance, to experimental, biological,
or coding errors) may put at risk the reliability of the inferences about the test’s accuracy (e.g., Walach et al.,
2017), we develop a robust additive (based on regression splines) modelling framework for conducting inference
about the covariate-specific ROC curve that mitigates the impact that outliers can have on inferences, while
simultaneously allowing for nonlinear effects of the covariates. Here and below, by an outlier or atypical test
outcome we mean an outcome that is clearly separated from the majority or bulk of the test outcomes, or that in
some way deviates from the general patterns present in the test results (Racine, 2019, p. 124). Our estimation
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method for the covariate-specific ROC curve is an induced approach, similar in spirit to those developed by
Pepe (1998), Gonza´lez-Manteiga et al. (2011), Rodr´ıguez-A´lvarez et al. (2011a), and Rodr´ıguez and Mart´ınez
(2014), which postulates a location-scale regression model for the test outcomes in both the diseased and
nondiseased populations. Yet, unlike previous approaches, (i) our specification for the regression function
relies on an additive cubic B-splines formulation, with M-estimation used for the regression coefficients, hence
safeguarding against outlying test outcomes, and (ii) the distribution of the regression errors is modelled via a
weighted empirical distribution function of the standardised residuals, therefore downweighting the influence of
outliers when estimating the covariate-specific ROC curve and its associated summary indices. These features
result in a widely applicable approach that can be used for many populations and for a large number of diseases
and continuous diagnostic tests. In addition, from a computational perspective, our method is extremely fast
and can be easily implemented in any software package. We acknowledge that the approaches of Gonza´lez-
Manteiga et al. (2011), Rodr´ıguez-A´lvarez et al. (2011a), and Rodr´ıguez and Mart´ınez (2014) also allow for
nonlinear effects of the covariates on the mean (and also on the variance) function but, unlike our proposed
approach, they do it through the use of kernel methods (the former two approaches) and Gaussian processes
(the latter approach).
The remainder of this paper is organised as follows. In the next section, we introduce our modelling
approach to conduct inference about the covariate-specific ROC curve. The performance of our method is
validated in Section 3 using simulated data under different test results’ contamination scenarios. In Section
4 our approach is applied to assess the age-specific accuracy of the Prostate Health Index as a biomarker for
prostate cancer. Concluding remarks are offered in Section 5.
2 ROBUST AND FLEXIBLE INFERENCE FOR THE COVARIATE-SPECIFIC ROC CURVE
2.1 Preliminaries
We start with some background on ROC curves. Let Y be the continuous random variable denoting the
outcome of the diagnostic test and D the binary variable indicating the presence (D = 1) or absence (D = 0)
of disease. Throughout, we use the subscripts D and D¯ to denote quantities conditional on D = 1 and D = 0,
respectively. For example, YD and YD¯ denote the test outcomes in the diseased and nondiseased populations,
with cumulative distribution functions given by FD and FD¯, respectively. Further, let c be the threshold value
used for defining a positive test result. Without loss of generality, we proceed with the assumption that larger
values of Y are more indicative of disease; that is, a subject is diagnosed as diseased when his/her test outcome
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is equal or greater than c, Y ≥ c, and he or she is diagnosed as nondiseased when the outcome is below c,
Y < c. Hence, for each possible threshold c, the true positive fraction (TPF) and false positive fraction (FPF)
corresponding to such decision criterion are
TPF(c) = Pr(Y ≥ c | D = 1) = Pr(YD ≥ c) = 1− FD(c),
FPF(c) = Pr(Y ≥ c | D = 0) = Pr(YD¯ ≥ c) = 1− FD¯(c).
The ROC curve is defined as the set of points {(FPF(c),TPF(c)) : c ∈ R} and, as it is clear from this
definition, it lies in the unit square. Letting t = FPF(c), the ROC curve can be alternatively expressed as
{(t,ROC(t)) : t ∈ [0, 1]}, with
ROC(t) = 1− FD{F−1D¯ (1− t)}.
ROC curves measure how separated the test outcomes in the diseased and nondiseased populations are (see
Figure 1 of the Supplementary Materials). When the test outcomes in the two populations completely overlap,
the ROC curve is the diagonal line of the unit square, that is, FPF(c) = TPF(c) for all c, thus indicating
a noninformative test. Conversely, the more separated the distributions of the test outcomes are, the closer
the ROC curve is to the point (0, 1) in the unit square and the better the diagnostic accuracy. A curve that
reaches the point (0, 1) has FPF(c) = 0 and TPF(c) = 1, for some threshold c and, hence, corresponds to a
test that perfectly determines the true disease status.
It is common to summarise the information of the ROC curve into a single summary index and, undeniably,
the most popular one is the area under the ROC curve (AUC), given by
AUC =
∫ 1
0
ROC(t)dt.
For a useless test that classifies individuals as diseased or nondiseased no better than chance, AUC = 0.5,
whereas for a perfect test, AUC = 1. In addition to its geometric definition, the AUC has also a probabilistic
interpretation (Pepe, 2003, p. 78),
AUC = Pr(YD ≥ YD¯),
that is, the AUC is the probability that the test outcome for a randomly chosen diseased subject exceeds the
one exhibited by a randomly selected nondiseased individual.
2.2 Modelling Framework for the Covariate-Specific ROC curve
Let X denotes the covariate vector and, for ease of notation, we will be assuming that the covariate vectors XD¯
and XD are the same in both populations. However, this is not necessarily always the case as, for instance,
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disease stage, which is a diseased-specific covariate, might be of interest. The key object of our modelling
framework is the covariate-specific ROC curve, which for a given covariate value x, is defined as
ROC(t | x) = 1− FD{FD¯(1− t | x) | x}, 0 ≤ t ≤ 1,
where FD(y | x) = Pr(YD ≤ y | XD = x) is the conditional cumulative distribution function in the diseased
population, with FD¯(y | x) being analogously defined. The covariate-specific counterpart of the AUC is given
by
AUC(x) =
∫ 1
0
ROC(t | x)dt. (1)
Note that in this setting, for each possible value x, we might obtain a different ROC curve/AUC and, therefore,
also a possible different accuracy.
We follow an induced approach and we further assume that the relationship between covariates and test
outcomes in each population is given by a location-scale regression model, i.e.,
YD = µD(x) + σDεD, YD¯ = µD¯(x) + σD¯εD¯, (2)
where µD(x) = E(YD | XD = x) and σD are the conditional mean function and scale parameter, respectively,
in the diseased population, with µD¯(x) and σD¯ similarly defined. The errors εD and εD¯ are independent of
each other and independent of the covariates XD and XD¯, with mean zero, unit variance, and cumulative
distribution functions given by FεD and FεD¯ , respectively. The independence between the error and the
covariates in the location-scale regression model, allows one to rewrite the conditional cumulative distribution
function of the test outcomes in terms of the cumulative distribution function of the regression errors
FD(y | x) = FεD
(
y − µD(x)
σD
)
, FD¯(y | x) = FεD¯
(
y − µD¯(x)
σD¯
)
. (3)
An analogous relationship holds between the conditional quantile function and the quantile function of the
error terms, namely
F−1D (t | x) = µD(x) + σDF−1εD (t), F−1D¯ (t | x) = µD¯(x) + σD¯F−1εD¯ (t).
The covariate-specific ROC curve can therefore be expressed as
ROC(t | x) = 1− FεD
{
µD¯(x)− µD(x)
σD
+
σD¯
σD
F−1εD¯ (1− t)
}
, 0 ≤ t ≤ 1.
An advantage of this formulation is that the distribution and quantile functions of the regression errors are not
conditional, thus alleviating the computational burden. Note that under this approach the effect of covariates
on the ROC curve is expressed in terms of their effects on the mean functions of each population.
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2.3 Proposed Robust and Flexible Estimator and its Implementation
Let {(xD¯i, yD¯i)}nD¯i=1 and {(xDj , yDj)}nDj=1 be two independent random samples of covariates and test outcomes
from the nondiseased and diseased populations of size nD¯ and nD, respectively. Further, for all i = 1, . . . , nD¯
and j = 1, . . . , nD, let xD¯i = (xD¯i,1, . . . , xD¯i,p)
′ and xDj = (xDj,1, . . . , xDj,p)′ be p-dimensional vectors of
covariates.
2.3.1 Modelling the Mean Function
From the location-scale models in (2), what needs to be specified is the regression function in each population.
We will describe our modelling approach for the diseased population, but everything follows similarly for the
nondiseased population. Since nonlinear relationships between test outcomes and continuous covariates often
occur, we assume a flexible additive formulation for the mean function, namely
µD(xDj) = βD0 + fD1(xDj,1) + · · ·+ fDp(xDj,p), j = 1, . . . , nD,
where fDh(·), h = 1, . . . , p, are smooth functions, each approximated by a linear combination of cubic B-splines
basis functions defined over a sequence of knots ξDh0 < ξDh1 < · · · < ξDhKDh < ξDh,KDh+1. The knots ξDh0
and ξDh,KDh+1 are boundary knots, while the remaining ones are interior knots. We then write
fDh(xDj,h) =
KDh+3∑
k=1
Bhk(xDj,h)βDhk = B
′
ξDh
(xDj,h)βDh, j = 1, . . . , nD, h = 1, . . . , p,
where Bk(x) denotes the kth cubic B-spline basis function (de Boor, 1978, Chapter 9) evaluated at x,
BξDh(xDj,h) = (Bh1(xDj,h), . . . , Bh,KDh+3(xDj,h))
′, βDh = (βDh1, . . . , βDh,KDh+3)
′. The mean function is thus
expressed as
µD(xDj) = βD0 + B
′
ξD1
(xDj,1)βD1 + · · ·+ B′ξDp(xDj,p)βDp
= z′DjβD, (4)
where zDj = (1,B
′
ξD1
(xDj,1), . . . ,B
′
ξDp
(xDj,p))
′ and βD = (βD0,βD1, . . . ,βDp)′. It is well-known that both
the number and location of knots characterising the B-splines basis functions are key choices that have the
potential to impact the inferences, more so the former than the latter. As noted in Durrleman and Simon
(1989), usually, only a few number of knots, say a maximum of three or four, are needed to adequately describe
most of the phenomena likely to be observed in medical statistics. In this paper, the selection of the number
of knots is assisted by a robust version of the Akaike information criterion (see Section 2.4). Regarding the
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location of the KDh interior knots, we follow Rosenberg (1995) and ξDhk is set equal to the k/(KDh + 1)
quantile of xD,h = (xD1,h, . . . , xDnD,h), for k = 1, . . . ,KDh and h = 1, . . . , p, thus assuring an approximate
equal number of observations at each interval defined by the knots. The boundary knots ξDh0 and ξDh,KDh+1
are set equal to the minimum and maximum of xD,h, respectively. For the ease of presentation, we have
assumed that all p covariates are continuous, but we can also easily deal with categorical covariates, as well
as, interactions between categorical covariates and interactions between a (smooth) continuous covariate and
a categorical one.
2.3.2 Robust Estimation
The representation in (4) reduces the estimation of µD(xDj) to the estimation of the coefficients βD. Moreover,
this expression is linear in the coefficient vector βD and therefore the estimation of µD(xDj) can be viewed
as an optimisation problem that is linear in the transformed variables zDj , therefore allowing the use of well-
established estimation techniques for multiple regression models. Estimation by ordinary least squares would
be the most natural option. However, least squares type of approaches, because they rely on (minimising) a
quadratic loss function, are extremely sensitive to outliers. Even a single atypical test outcome can drastically
affect the estimated regression coefficients. Moreover, the scale parameter σD is traditionally estimated by the
square root of σ̂2D = (nD − QD)−1
∑nD
j=1(yDj − z′Djβ̂OLSD )2, which is not robust either. Note that here QD is
the dimension of the vector zDj and β̂
OLS
D is the least squares estimate of βD. It could be tempting to remove
the outlying test outcomes using, for instance, graphical or residual analysis, and then obtaining the least
squares estimates of the regression coefficients based on the ‘clean’ sample. However, this strategy, might be
not only impractical, but might also lead to inferences that are neither valid nor robust (Welsh and Ronchetti,
2002), not to mention the reduction in sample size. One way to circumvent this problem is to minimise a less
rapidly increasing function than the squared one, so that the influence of test outcomes with large residuals
is reduced. For instance, least absolute deviation regression, which minimises the absolute value loss function,∑nD
j=1|yDj−z′DjβD|, leads to estimators that are highly resistant to outliers (in the response variable). However,
the drawback is that such estimators are relatively inefficient. An elegant compromise between the squared
and absolute value loss functions was proposed by Huber (1964), who suggested to estimate βD as
β̂D = arg min
βD
nD∑
j=1
ρ
(
yDj − z′DjβD
σ̂D
)
, ρ(u) =

u2
2 , |u| ≤ b,
b|u| − b22 , |u| > b,
(5)
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where b is a tuning constant and σ̂D is a robust estimate of scale. Huber’s loss function is quadratic for
small values of the standardised residuals but grows linearly for large absolute values of the standardised
residuals. The tuning constant b describes where the transition from a quadratic to a linear loss function takes
place, thus allowing for different compromises between robustness and efficiency, and acting like a threshold
such that observations with standardised residuals larger, in absolute value, than b have a reduced effect in
the estimation. For larger values of b, Huber’s loss function becomes more similar to the least squares loss
function, whereas for small values of b, it is more similar to the absolute value loss function. The typical choice
of b is 1.345, for which Huber (1964) showed that the resulting estimator is, asymptotically, 95% as efficient
as the least squares estimator when the true distribution of the errors is normal. Although we do not make
any distributional assumption about εD, we shall use b = 1.345. In (5), the robust estimate of the scale σ̂D,
needed to ensure that the resulting estimate of βD is scale equivariant, is in our case the re-scaled median
absolute deviation of the residuals
σ̂D = 1.4826 median
j=1,...,nD
|yDj − z′Djβ̂D|, (6)
with the constant 1.4826 based on a normality assumption. Huber’s estimator falls under the general category
of M-estimators (e.g. Maronna et al., 2019, Chapters 2–5). The M-estimator minimises (5) or, equivalently,
solves the system of estimating equations
nD∑
j=1
ψ
(
yDj − z′DjβD
σ̂D
)
zDj = 0QD , ψ(u) =
d
du
ρ(u) =

u, |u| ≤ b,
b sign(u), |u| > b,
(7)
where sign(u) = I(u > 0)− I(u < 0) and with sign(0) = 0. Defining the weight function ω(u) by
ω(u) =
ψ(u)
u
=

1, |u| ≤ b,
b
|u| , |u| > b,
allows us to rewrite Equation (7) as
nD∑
j=1
ωDj
(
yDj − z′DjβD
)
zDj = 0QD , ωDj = ω
(
yDj − z′DjβD
σ̂D
)
. (8)
In Figure 2 of the Supplementary Materials we present a comparison between Huber’s ρ, ψ, and ω functions
and the corresponding least squares and least absolute deviation counterparts for a better understanding of
their behaviour. Note that, for instance, least squares assigns equal weight to all observations, whereas Huber’s
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based weight function assigns decreasing weights for observations with large, in absolute value, standardised
residuals. The system of equations in (8) can be written in matrix form as
Z′DΩDZDβD = Z
′
DΩDyD,
where ZD is a matrix with z
′
Dj as its jth row, ΩD is a diagonal matrix with entries given by ωDj , for
j = 1, . . . , nD, and yD = (yD1, . . . , yDnD)
′, and therefore can be regarded as a weighted least squares problem
whose solution is given by β̂D = (Z
′
DΩDZD)
−1Z′DΩDyD and which is guaranteed to be unique because Huber’s
loss function ρ is convex. Because the weights depend upon the estimated regression coefficients and scale
parameters and, in turn, these depend upon the weights, the iteratively reweighted least squares procedure is
employed. The algorithm can be briefly summarised by the following two steps.
Step 1: Obtain an initial estimate β̂
(0)
D , which can be based, for instance, on a least squares fit. Use β̂
(0)
D to
obtain σ̂
(0)
D using the re-scaled median absolute deviation of the residuals as in (6). Compute an initial
estimate of Ω(0) using β̂
(0)
D and σ̂
(0)
D .
Step 2: At iteration k = 1, 2, . . ., solve for the new weighted least squares estimate
β̂
(k)
D = (Z
′
DΩ
(k−1)
D ZD)
−1Z′DΩ
(k−1)
D yD. This estimate will be used to obtain σ̂
(k)
D and to compute Ω
(k)
D
which, in turn, will form the basis of β̂
(k+1)
D . The iterative procedure is run until some convergence
criterion is met.
The converged estimate β̂D is taken as our final robust estimate of βD and used to obtain the final estimate
σ̂D of σD. We note here that β̂D based on Huber’s loss function is not robust against outliers in the covariates.
Once estimates β̂D and σ̂D have been obtained, the distribution function of the error εD is estimated on
the basis of the weighted empirical distribution function of the standardised residuals, i.e.,
F̂εD(y) =
nD∑
j=1
qDjI (ε̂Dj ≤ y) , ε̂Dj = yDj − µ̂D(xDj)
σ̂D
, qDj =
ωDj∑nD
l=1 ωDl
, µ̂D(xDj) = z
T
Djβ̂D. (9)
The purpose of using a weighted version of the empirical distribution function is to downweight the influence
of outliers on its estimation and, consequently, on the estimation of the covariate-specific ROC curve and
associated AUC. The empirical distribution function is recovered when ωDj = 1, for all j = 1, . . . , nD. Our
computational experiences (not shown) have demonstrated that using Huber’s estimates β̂D and σ̂D in con-
junction with the empirical distribution function, rather than its weighted version, would lead to estimators
of ROC(t | x) and AUC(x) that cannot cope with contamination levels above 5% in each population.
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Finally, the ROC curve estimate can be written as
R̂OC(t | x) = 1− F̂εD
{
µ̂D¯(x)− µ̂D(x)
σ̂D
+
σ̂D¯
σ̂D
F̂−1εD¯ (1− t)
}
, (10)
and the corresponding AUC admits the following closed-form expression, derived in the Appendix, and which
can be regarded as a weighted robust covariate-specific Mann–Whitney type of statistic
ÂUC(x) =
1∑nD
l=1 ωDl
∑nD¯
l=1 ωD¯l
nD∑
j=1
nD¯∑
i=1
ωDjωD¯iI{µ̂D¯(x) + σ̂D¯ε̂D¯i ≤ µ̂D(x) + σ̂Dε̂Dj}. (11)
2.3.3 Implementation
Some final comments on implementation are in order. Our procedure is easily implemented in R (R Core
Team, 2020) using the bs function from the package splines (to create the cubic B-splines basis expansions)
in combination with the rlm routine from the MASS package (Venables and Ripley, 2002), which performs the
robust estimation procedure described above to obtain β̂D and σ̂D. Of course, M-estimation for generalised
additive models based on a smoothing parameter/penalty (as, e.g., in Wong et al. 2014) would be an alternative
route, but these tend to involve intricate and computationally expensive algorithms. Under our approach,
regularisation is achieved through selecting the number of interior knots, which we do with the aid of a
robust Akaike information criterion, as we explain in the next section. This results in a simple and fast, yet
effective, estimation procedure. The R code implementing our approach is publicly available at (github link
upon acceptance).
2.4 Robust Akaike Information Criterion
The issue of selecting the number of interior knots for each smooth function of a continuous covariate can be
regarded as a model selection problem. Here, and because the classical Akaike information criterion (AIC)
is sensitive to outlying observations, such choice is assisted through the use of a robust version of the AIC,
denoted by rAIC, that is suited for M-estimation and which was proposed by Tharmaratnam and Claeskens
(2013). Specifically, the authors suggest to use
rAICD = 2nD log σ̂D + 4 trace(J
−1
D,nD
UD,nD), (12)
where the empirical information matrices in the trace term (the penalty term) are calculated as follows
JD,nD =
1
nD
nD∑
j=1
ψ′
(
yDj − z′Djβ̂D
σ̂D
)
zDjz
′
Dj
σ̂2D
, UD,nD =
1
nD
nD∑
j=1
ψ2
(
yDj − z′Djβ̂D
σ̂D
)
zDjz
′
Dj
σ̂2D
.
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Models with a varying number of interior knots will be fitted, βD and σD are re-estimated in each model and
the corresponding rAIC is computed, and the model with the smallest rAIC will be selected. When several
continuous covariates are involved, our strategy involves exploring the set of all possible models. This is viable
because not only our fitting procedure is extremely fast, but also because in medical diagnostic studies the
number of continuous covariates available is often reduced and, as mentioned before, usually a modest number
of knots suffices to describe the relationship between covariates and test outcomes. On a related task, the rAIC
can also be used to select between a linear or smooth effect of a given (continuous) covariate. It is important
to remark that the penalty term needs to be changed to 2 trace(J−1D,nDUD,nD) if instead of using the ψ function
in (7), one uses 2ψ(u) (as, e.g., in Tharmaratnam and Claeskens 2013).
2.5 Robust Bootstrap-based Inference for the Robust and Flexible Covariate-Specific
ROC Curve
Confidence intervals for the covariate-specific ROC curve and corresponding AUC can be obtained through
the bootstrap. Some bootstrap samples may have a proportion of outliers much higher than in the original
one, thus placing at risk the contamination level tolerated by Huber’s M-estimator and consequently severely
affecting the recomputed quantities (regression coefficients, standard deviations, etc). Hence, we use a robust
bootstrap of the residuals to resample the (robust) regression model in each population. Specifically, each
standardised residual ε̂Dj (ε̂D¯i) is sampled with probability proportional to ωDj (ωD¯i), for j = 1, . . . , nD
(i = 1, . . . , nD¯). The details of our bootstrap scheme, for b = 1, . . . , B, are as follows:
Step 1: Sample with replacement, with probabilities {ωD¯i/
∑nD¯
l=1 ωD¯l}
nD¯
i=1 and {ωDj/
∑nD
l=1 ωDl}nDj=1, from the
estimated standardised residuals {ε̂D¯i}nD¯i=1 and {ε̂Dj}nDj=1 to form bootstrap sets {ε̂(b)D¯i}
nD¯
i=1 and {ε̂(b)Dj}nDj=1.
Step 2: Use the mean function and variance estimates from the observed data to construct bootstrap samples
{(xD¯i, y(b)D¯i)}
nD¯
i=1 and {(xDj , y(b)Dj)}nDj=1, where
y
(b)
D¯i
= µ̂(xD¯i) + σ̂D¯ε̂
(b)
D¯i
, y
(b)
Dj = µ̂(xDj) + σ̂Dε̂
(b)
Dj .
Step 3: Repeat the estimation process with the bth bootstrap sample, thus obtaining R̂OC
(b)
(p | x) and
ÂUC
(b)
(x).
Once this process has been completed, and according to the percentile method, a bootstrap confidence interval
for, e.g., AUC(x), of confidence level 1− α is given by(
ÂUC
α/2
(x), ÂUC
1−α/2
(x)
)
,
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where ÂUC
τ
(x) represents the τth percentile of the ensemble of estimates {ÂUC(b)(x)}Bb=1.
3 SIMULATION STUDY
To evaluate the empirical performance of our robust and flexible approach for conducting inference about
the covariate-specific ROC curve and corresponding AUC, we analysed simulated data under four different
scenarios (described in the next section). For each scenario, 1000 data sets were generated using sample sizes
of (nD¯, nD) = (100, 100), (nD¯, nD) = (200, 100), and (nD¯, nD) = (200, 200). The following percentages of test
outcomes contamination, in each population, were considered: 2%, 5%, and 10%. The case of no contamination
(original simulated datasets) was also considered in order to ascertain the performance of our method when a
robust approach is not needed at all.
3.1 Simulation Scenarios
In Scenario I, we consider different homoscedastic linear mean regression models for the nondiseased and
diseased populations, namely
yD¯i | xD¯i,1 ind.∼ N
(
0.5 + xD¯i,1, 1.5
2
)
, yDj | xDj,1 ind.∼ N
(
2 + 4xDj,1, 2
2
)
, i = 1, . . . , nD¯, j = 1, . . . , nD.
The primary purpose of including this scenario is to allow us assessing the impact of using a cubic B-splines
basis formulation for the mean function of each population when the underlying true effect is, in fact, linear.
Data for Scenario II are governed by the following nonlinear mean regression models
yD¯i | xD¯i,1 ind.∼ N
(
sin{pixD¯i,1}, 0.52
)
, yDj | xDj,1 ind.∼ N
(
1 + x2Dj,1, 1
2
)
.
Scenario III involves heteroscedastic nonlinear mean regression models for the diseased and nondiseased pop-
ulations
yD¯i | xD¯i,1 ind.∼ N
(
0.5 sin{2pixD¯i,1}, (1 + 0.75xD¯i,1)2
)
, yDj | xDj,1 ind.∼ N
(
0.5 + sin{pixDj,1}, (1 + xDjx,1)2
)
.
Note that our model is actually misspecified in this case as it does not allow the variance to change with the
covariates and the goal of including this scenario is exactly to assess the performance of our approach when
the assumption of constant variance does not hold. Finally, in Scenario IV we have considered the case where
two continuous covariates affect the test outcomes
yD¯i | xD¯i,1, xD¯i,2 ind.∼ N
(
0.5 + xD¯i,1 + x
2
D¯i,2, 1.5
2
)
, yDj | xDj,1, xDj,2 ind.∼ N
(
2 + 4x3Dj,1 + 1.5xDj,2, 2
2
)
.
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In all cases, the continuous covariates x1 and x2, are independently generated from uniform distributions,
namely
xD¯i,1
i.i.d.∼ U(0, 1), xD¯i,2 i.i.d.∼ U(0, 2), xDj,1 i.i.d.∼ U(0, 1), xDj,2 i.i.d.∼ U(0, 2).
Further, in all scenarios, the contaminated data were generated by randomly selecting a given percentage of
test outcomes and replacing them by N{µD¯(xD¯) +κD¯σD¯(xD¯), σ2D¯(xD¯)} and N{µD(xD) +κDσD(xD), σ2D(xD)}
(shift in the location outliers) in the nondiseased and diseased populations, respectively. Note that for all
scenarios but the third we have σD¯(xD¯) ≡ σD¯ and σD(xD) ≡ σD. Additionally, we have considered κD¯ = 15
and κD = 20, which at a first glance might seems excessive but it is indeed in line with what we observe in
our data application in Section 4 (see also the left panel of Figure 3). The impact of the magnitude of those
values on the estimates will be discussed in the Results section.
3.2 Models
For each simulated dataset we fit our robust and flexible approach considering no interior knots for each
continuous covariate in each population (i.e., KD¯1 = KD¯2 = KD1 = KD2 = 0). A further inspection to this
choice is discussed in the next section. Our model is compared to the semiparametric approach of Pepe (1998),
which is based on a location-scale regression model for the test outcomes in each population that relies on a
linear formulation for the mean function and with the regression coefficients estimated, for instance, by least
squares. In addition to the original approach proposed by Pepe (1998), we have also considered an extension
of this method by using a cubic B-splines trend, also with no interior knots, so that direct comparisons to our
approach are easier and fairer. The only difference between ours and this approach is the objective function
(least squares versus Huber’s ρ function). In addition, our method is also compared to the nonparametric
approach of Rodr´ıguez-A´lvarez et al. (2011a), which relies on kernel-based estimators for the mean and variance
functions of the location-scale model. The main difference to the method of Gonza´lez-Manteiga et al. (2011)
is the order of the local polynomial smoothers used for estimating the regression function; while Gonza´lez-
Manteiga et al. (2011) employed a local constant fit (order 0), Rodr´ıguez-A´lvarez et al. (2011a) considered a
linear fit (order 1). Because local constant regression suffers from boundary–bias problems, we only considered
the latter approach. All competing methods were implemented using the ROCnReg package (Rodr´ıguez-A´lvarez
and Ina´cio, 2020) which, in turn, relies on the np package (Hayfield and Racine, 2008) for kernel estimation.
Still on the kernel method, it is important to remark that the bandwidth parameters involved in the estimation
process were selected using least-squares cross-validation and that this approach, as it stands now, can only
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deal with one continuous covariate.
3.3 Results
The case (nD¯, nD) = (200, 100), which is similar to the prostate cancer application in Section 4, is shown
here and we first analyse Scenarios I–III. The estimated (mean of the 1000 Monte Carlo estimates) covariate-
specific AUC along with the 2.5% and 97.5% simulation quantiles in Figure 1 illustrate the ability of our
model to accurately and precisely capture complex functional forms in a case where the contamination in
each population is 5%. As can be observed in Figure 1, the three non-robust estimators have a very poor
performance, showing some bias and wide simulation quantiles bands. Further, and obviously, the original
estimator proposed by Pepe (1998) is inadequate for scenarios involving nonlinear trends. Also, note that in
Scenario III, where the underlying regression models in the two populations are heteroscedastic, our estimator
still has a very decent performance, although we expect it to deteriorate for more substantial changes in the
variance along with the covariate. We further note that in this scenario involving heteroscedasticity and when
there is no contamination of the test outcomes, the kernel approach, because it models the variance as a
function of covariates, it is the one showing less bias (Figure 11 in the Supplementary Materials).
The remaining sample sizes and percentages of contamination are shown in Figures 3 to 14 in the Supple-
mentary Materials and although similar conclusions were found, some comments are in order. First, even in
the case of no contamination, Figures 3, 7, and 11 in the Supplementary Materials, corresponding, respectively,
to Scenario I, II, and III, the performance of our robust and flexible estimator is almost on par with that of the
non-robust estimators (with the exception of Pepe (1998) for Scenarios II and III). Second, in the case of a 2%
contamination (see Figures 4, 8, and 12 in the Supplementary Materials), the non-robust estimators already
show some bias and an increase in the width of the simulation bands. This is, of course, much more marked
for the case of 10% contamination. In turn, the performance of our robust estimator remains unchanged.
For Scenario IV, which involves two continuous covariates, only our estimator was considered. We regard
this scenario mainly as a proof of concept when there are multiple continuous covariates and the results obtained
from fitting the competing approaches were similar to those reported for Scenarios I–III. Nonetheless, for the
three sample sizes and different percentages of contamination considered, our approach performs very well and
is able to recover the different profiles of the true covariate-specific surface (Figure 2 and Figures 15–18 in the
Supplementary Materials).
We shall remark that although the covariate-specific AUC admits the closed-form expression in (11), its
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calculation can be very time-consuming, especially for large datasets. As a consequence, here and in the
Application section, the integral in (1) was approximated using Simpson’s rule. In our experience Simpson’s
rule provides almost identical results to the ones obtained using the closed-form expression.
Because we rely on the robust AIC to assist in the selection of the number of knots needed in the regression
function, we have investigated the behaviour of this criterion when performing such a task. Specifically, over
the 1000 simulated datasets, for each scenario considered, for the different sample sizes in each population
(100 and 200) and for the different contamination percentages, we computed the number of times the robust
AIC favoured the model with no interior knots over a model with three interior knots. For this latter model,
following the rule discussed in Section 2, the knots are located at the 0.25, 0.5, and 0.75 quantiles of the
covariates. Note that for Scenario IV, as a slight simplification, we have assumed the same number of knots
for both continuous covariates (i.e., (KD1,KD2) = (0, 0) and (KD1,KD2) = (3, 3), with the same applying in
the nondiseased population). Results are displayed in Tables 1–4 in the Supplementary Materials and show
that, most of the time, the robust AIC favoured the simpler model with no interior knots over the more
complex model with three interior knots. For instance, in Scenario I, where the regression function assumes a
linear form in both populations, our intuition would dictate that the model with no interior knots should be
selected for a large number of the simulated datasets and Table 1 (Supplementary Materials) confirms exactly
this. Also, in Scenario 4, the model with no interior knots for the two covariates (and that involves seven
regression parameters) is favoured most of the time over the model that uses three interior knots for each of
the covariates (and that involves thirteen regression parameters).
We conclude this section with some extra important remarks. Although we have assumed that both popu-
lations were subject to contamination, it may happen that only test outcomes from one of the populations are
contaminated. Simulation results (not shown) indicate that in such cases the robust estimator still outperforms
the non-robust competitors. However, and interestingly, even when assuming balanced sample sizes, contami-
nation in the nondiseased population seems to impact much more the ability of the non-robust estimators to
recover the true functional form of the AUC than contamination in the diseased population. Our intuitive
explanation, bearing in mind Equation (10), is that estimation of the quantile function of the standardised
residuals is more impacted by outliers than the estimation of the cumulative distribution function (of the
standardised residuals). Further, a shift of 15σD¯(xD¯) and 20σD(xD) in the location of the distribution of the
test outcomes in the nondiseased and diseased populations, respectively, was considered. Our computational
experiences show that the performance the non-robust estimators is affected by the magnitude of those shifts
and, as expected, the larger the shift, the worse the performance. For instance, for a very large shift, which
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we acknowledge to be unlikely in practice but only to make our point, even the case of a contamination of 2%
would be enough to strongly impact their performance. On the other hand, the performance of the proposed
robust estimator is basically unchanged by the magnitude of the shifts, as outlying test outcomes would receive
very little weight in the estimation procedure. To make this point concrete, Figure 19 in the Supplementary
Materials shows the results, under Scenario I, 2% of contamination and (nD¯, nD) = (200, 200), of considering
κD = κD¯ = 50. As can be noticed, and especially when compared to row 3 of Figure 4, there is a substantial
increase in the bias and width of the 95% simulation bands. We should also mention that having also simulated
contaminated samples considering radial outliers, which arise by multiplying the scale of the distribution of
test outcomes in each group by a given factor, results remained basically the same and therefore are not shown
here. Finally, our computational experiences also revealed that with contamination percentages of about 25%
onwards (in each population), the performance of our estimator starts deteriorating.
4 APPLICATION
4.1 Motivation and Exploratory Analysis
Prostate cancer (PCa) is the second most frequent cancer diagnosed in men, only after lung cancer, and
amounts to the fifth highest cause of death worldwide (Rawla, 2019). Gleason histological scoring system is
the most reliable system used for the grading of prostate cancer, but it requires invasive tissue biopsies. This,
and the rising incidence of prostate cancer worldwide, have led to the search of less invasive biomarkers that
can accurately predict the presence of PCa. The Prostate Health Index (PHI), that combines three prostate
specific antigen subforms into a single score using a mathematical formula, has been introduced (Le et al.,
2010) and since then several studies have shown that it significantly improves prediction of a positive biopsy
when compared to the prostate specific antigen across different ranges (e.g., Stephan et al., 2013; Wang et al.,
2014; De La Calle et al., 2015). The PHI is now approved by the US Food and Drug Administration and
it has also been adopted into the US National Cancer Network guidelines. We apply our methods to data
from a study designed to assess the added value of the PHI to multi-parametric magnetic resonance imaging
in detecting significant prostate cancers (Gleason ≥ 7) in a repeat biopsy population (Gnanapragasam et al.,
2016). Here our goal is slightly distinct and we seek to assess, if and how, the ability of the PHI to discriminate
between men with benign or Gleason 6 PCa (which throughout we refer as the nondiseased goup and for which
nD¯ = 185) and men with Gleason 7 or above PCa (which we term as the diseased group and for which nD = 94),
changes with age. To the best of our knowledge, this is the first attempt to study the possible age effect on
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the accuracy of the PHI to distinguish between those two PCa groups. In Figure 3 (left panel) we show the
histograms of the PHI levels in the two populations and it can be observed that, as expected, men belonging
to the group defined by Gleason ≥ 7 tend to have higher PHI values than those with a benign lesion or with
a Gleason of 6. We can also notice that although the majority of PHI values lie below 100 in the nondiseased
group and below 150 in the diseased group, there are two PHI scores, one from each group, above 200.
4.2 Unconditional and Age-Specific ROC Analysis
We start our analysis by calculating the AUC when ignoring the potential age effect and we have computed it
in a robust way (so that it is more easily comparable to the covariate-specific AUCs we will present later) as
ÂUC =
1∑nD
l=1 ωDl
∑nD¯
l=1 ωD¯l
nD∑
j=1
nD¯∑
i=1
ωDjωD¯i
{
I(yD¯i < yDj) +
1
2
I(yD¯i = yDj)
}
,
where the weights ωD¯i and ωDj arise from fitting, in each group, a robust regression model with the PHI
scores as the responses and with only an intercept term. Although PHI outcomes are defined on a continuous
scale, in practice ties can occur, and so the extra term (1/2) × I(yD¯i = yDj) corrects for such possible ties.
The resulting AUC estimate (95% bootstrap confidence interval based on 1000 resamples) is 0.75 (0.70, 0.83),
revealing a reasonably good capacity of the PHI levels to discriminate between men with a Gleason of 6 or a
benign lesion and men with Gleason ≥ 7.
We now turn our attention to the inclusion of age in the analysis. In Figure 3 (middle and right panels)
are depicted the scatter plots of the data in each group along with the estimated regression functions; the
robust AIC in (12) led to KD1 = KD¯1 = 0 (no interior knots), with these selected from the set {0, 1, 2, 3, 4}.
Firstly, both scatter plots do not indicate any departure from the homoscedasticity assumption. Note that the
higher PHI outcomes are properly weighted under our robust scheme; for instance, the PHI scores above 200
in the nondiseased and diseased groups receive a weight of 0.09 and 0.19, respectively. Secondly, as a result
of the weighting scheme, such high PHI values do not push the regression functions towards them as much
as the analogous least squares counterparts (shown in Figure 20 of the Supplementary Materials). Note that
for a fairer comparison we have also included, in Figure 20 of the Supplementary Materials, an approach that
models the mean function through a cubic B-splines basis expansion with no interior knots. Thirdly, while in
the nondiseased group the PHI does not show any noticeable dynamic along age, in the diseased group there
seems to be evidence that older ages are associated with higher PHI outcomes. In Figure 4 (left and middle
panels), we present two different age-specific ROC curves, namely, for ages of 57 and 73 years old, with the
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corresponding AUCs being 0.72 (0.56, 0.89) and 0.79 (0.71, 0.91), respectively. As can be seen, the ROC curves
are somewhat jagged, which is due to the fact of them being based on the (weighted) empirical distribution
function of the standardised residuals. To inspect the age effect further, Figure 4 (right panel) shows a plot
of the age-specific AUC for ages between 55 and 75 years old and we can observe that the capacity of the
PHI levels to distinguish between men with benign or Gleason 6 PCa and men with Gleason ≥ 7 PCa slightly
increases with age, ranging from 0.71 (0.52, 0.89) for a men of 55 years old to 0.84 (0.73, 0.95) for a men of 75
years old. The AUC estimate obtained when ignoring the age effect was 0.75 and so, roughly, for individuals
younger than 70 years we would be slightly overestimating the accuracy of the PHI scores and for individuals
older than 70 years old such accuracy would be underestimated. Nonetheless, note that the unconditional
AUC estimate and corresponding 95% confidence interval are contained in the 95% bootstrap confidence band
for all ages considered and so it is difficult to draw firm conclusions about the age effect. We remark that AUC
predictions were only considered for ages in the the interval (55, 75) as this corresponds to the range where both
groups had a reasonable number of observations. We further remark that when computing the 95% bootstrap
confidence bands, the number of internal knots selected for the observed data (in this case this was 0 for both
groups) was used when re-computing the estimates for the generated bootstrap samples. Also we highlight
that it took less than one minute to run our model (including the 1000 bootstrap resamples) on a MacBook
Pro with 2.3GHz Intel i5 processor and 8GB RAM. Finally, in Figure 21 of the Supplementary Materials we
present the age-specific AUC estimates obtained when considering the three non-robust estimators detailed in
the Simulation Study section, and as can be observed they are not markedly different from the point estimate
provided by our approach. This should come as no surprise as the estimated mean functions were also not too
distinct, which makes sense as there are only two PHI outcomes, one in each group, that lie well above the
remaining scores. Also, all approaches agree that the accuracy of the PHI scores to distinguish between the
two groups of PCa slightly increases with age.
5 CONCLUDING REMARKS
In this work we have developed a flexible and robust modelling framework for estimating the covariate-specific
ROC curve and corresponding AUC that assumes a location-scale regression model in both the diseased and
nondiseased populations and that combines an additive cubic B-splines formulation for the mean function with
M-estimation. Our approach is thus able to simultaneously accommodate nonlinear effects of the covariates
and outlying test outcomes. The proposed methodology has the additional appealing features of being simple
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and computationally inexpensive. The simulation study conducted illustrated the ability of our method to
recover the true shape of the covariate-specific ROC curve and AUC in a variety of complex scenarios involving
different test outcome distributions and contamination percentages. Our investigation into the potential of
the Prostate Health Index to distinguish between men with a benign lesion or a Gleason 6 prostate cancer
and men with aggressive prostate cancer (Gleason 7 or above) found that its accuracy slightly increases with
age. Although in this particular case the overall message of our analysis agrees with that provided by the
non-robust estimators, our approach enabled us to identify one outlying test outcome in each population.
Our method can be trivially adapted to also estimate the covariate-specific Youden index and its corre-
sponding optimal threshold. In particular, since
YI(x) = max
c
{FD¯(c | x)− FD(c | x)}, (13)
one can make use of the result in (3) and estimate the cumulative distribution function of the standardised
residuals using (9). The covariate-specific optimal threshold is the one maximising (13).
Although we have focused on a clinical context, ROC curves are also popular in other areas. For instance,
ROC curves are widely used in machine learning to evaluate classification algorithms. Indeed, the use of ROC
curves has greatly increased over the years. Quoting Gneiting and Vogel (2018, p. 1) “In 2017, nearly 8000
papers were published that use ROC curves, up from less than 50 per year through 1990 and less than 1000
papers annually through 2002.” Thus, our approach has the potential to be applicable beyond the medical
context explored here.
Finally, throughout we have assumed that only the test outcomes were prone to outliers. However, if
covariates are also contaminated, our approach can be easily extended to cope with this case by considering
MM-estimation techniques instead of the M-estimation method used here.
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APPENDIX
Here we deduce the representation of our weighted robust covariate-specific AUC in the form of (11). The
derivation is based on simple calculus and its main steps are outlined below. We start by noting that
ÂUC(x) =
∫ 1
0
R̂OC(t | x)dt
=
∫ 1
0
[
1− F̂εD
{
µ̂D¯(x)− µ̂D(x)
σ̂D
+
σ̂D¯
σ̂D
F̂−1εD¯ (1− t)
}]
dt
=
∫ 1
0
nD∑
j=1
ωDj∑nD
l=1 ωDl
I
{
ε̂Dj ≥ µ̂D¯(x)− µ̂D(x)
σ̂D
+
σ̂D¯
σ̂D
F̂−1εD¯ (1− t)
}
dt,
which implies that
ÂUC(x) =
1∑nD
l=1 ωDl
nD∑
j=1
ωDj
∫ 1
0
I
{
t ≥ 1− F̂εD¯
(
µ̂D(x)− µ̂D¯(x)
σ̂D¯
+
σ̂D
σ̂D¯
ε̂Dj
)}
dt
=
1∑nD
l=1 ωDl
nD∑
j=1
ωDj
∫ 1
1−F̂εD¯
(
µ̂D(x)−µ̂D¯(x)
σ̂D¯
+
σ̂D
σ̂D¯
ε̂Dj
) dt
=
1∑nD
l=1 ωDl
nD∑
j=1
ωDj
nD¯∑
i=1
ωD¯i∑nD¯
l=1 ωD¯l
I
{
ε̂D¯i ≤
µ̂D(x)− µ̂D¯(x)
σ̂D¯
+
σ̂D
σ̂D¯
ε̂Dj
}
=
1∑nD
l=1 ωDl
∑nD¯
l=1 ωD¯l
nD∑
j=1
nD¯∑
i=1
ωDjωD¯iI{µ̂D¯(x) + σ̂D¯ε̂D¯i ≤ µ̂D(x) + σ̂Dε̂Dj}.
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Figure 1: True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along with the 2.5%
and 97.5% simulation quantiles (shaded area) for the case of 5% contamination. The first row displays the results for Scenario
I, the second row for Scenario II, and the third row for Scenario III. The first column corresponds to our flexible and robust
estimator, the second column to the estimator proposed by Pepe (1998), the third one to the cubic B-splines extension of Pepe
(1998), and the fourth column to the kernel estimator. For all scenarios (nD¯, nD) = (200, 100).
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Figure 2: Scenario IV. Multiple profiles of the true covariate-specific AUC (solid line) versus the mean of the Monte Carlo
estimates (dashed line) along with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 5% contamination and
for (nD¯, nD) = (200, 100).
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Figure 3: Left panel: histogram of the PHI scores from the nondiseased (blue) and diseased (red) populations. Middle and
right panels: regression functions resulting from fitting our approach. The solid line is the point estimate, while the shaded areas
represent the 95% bootstrap confidence bands (based on 1000 resamples).
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estimate, while the shaded areas represent the 95% bootstrap confidence bands (based on 1000 resamples).
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SUPPLEMENTARY MATERIALS
In this supplementary file we provide additional figures and tables.
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Figure 1: Hypothetical densities of test outcomes in the diseased (dotted line, orange) and nondiseased (solid line, blue)
populations (top) along with the corresponding ROC curves (bottom).
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Figure 2: ρ, ψ, and ω functions for the least-squares (first row), least absolute deviation (second row) and Huber (third row)
estimators.
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Figure 3: Scenario I. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along
with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of no contamination. The first row displays the results
for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first column
corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third one to
the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 4: Scenario I. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along
with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 2% contamination. The first row displays the results
for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first column
corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third one to
the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 5: Scenario I. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along
with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 5% contamination. The first row displays the results
for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first column
corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third one to
the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 6: Scenario I. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along
with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 10% contamination. The first row displays the results
for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first column
corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third one to
the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 7: Scenario II. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along
with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of no contamination. The first row displays the results
for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first column
corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third one to
the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 8: Scenario II. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along
with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 2% contamination. The first row displays the results
for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first column
corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third one to
the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 9: Scenario II. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along
with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 5% contamination. The first row displays the results
for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first column
corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third one to
the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 10: Scenario II. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along
with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 10% contamination. The first row displays the results
for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first column
corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third one to
the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 11: Scenario III. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line)
along with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of no contamination. The first row displays the
results for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first
column corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third
one to the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 12: Scenario III. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line)
along with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 2% contamination. The first row displays the
results for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first
column corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third
one to the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 13: Scenario III. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line)
along with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 5% contamination. The first row displays the
results for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first
column corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third
one to the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 14: Scenario III. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line)
along with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 10% contamination. The first row displays the
results for (nD¯, nD) = (100, 100), the second row for (nD¯, nD) = (200, 100), and the third row for (nD¯, nD) = (200, 200). The first
column corresponds to our flexible and robust estimator, the second column to the estimator proposed by Pepe (1998), the third
one to the cubic B-splines extension of Pepe (1998), and the fourth column to the kernel estimator.
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Figure 15: Scenario IV. Multiple profiles of the true covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along with
the 2.5% and 97.5% simulation quantiles (shaded area) for the case of no contamination. Rows 1 and 2 displays the results for (nD¯, nD) = (100, 100), rows 3 and
4 for (nD¯, nD) = (200, 100), and rows 5 and 6 for (nD¯, nD) = (200, 200).
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Figure 16: Scenario IV. Multiple profiles of the true covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along with
the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 2% contamination. Rows 1 and 2 displays the results for (nD¯, nD) = (100, 100), rows 3 and
4 for (nD¯, nD) = (200, 100), and rows 5 and 6 for (nD¯, nD) = (200, 200).
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Figure 17: Scenario IV. Multiple profiles of the true covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along with
the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 5% contamination. Rows 1 and 2 displays the results for (nD¯, nD) = (100, 100), rows 3 and
4 for (nD¯, nD) = (200, 100), and rows 5 and 6 for (nD¯, nD) = (200, 200).
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Figure 18: Scenario IV. Multiple profiles of the true covariate-specific AUC (solid line) versus the mean of the Monte Carlo estimates (dashed line) along with
the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 10% contamination. Rows 1 and 2 displays the results for (nD¯, nD) = (100, 100), rows 3
and 4 for (nD¯, nD) = (200, 100), and rows 5 and 6 for (nD¯, nD) = (200, 200).
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Figure 19: Scenario I and κD = κD¯ = 50. True covariate-specific AUC (solid line) versus the mean of the Monte Carlo
estimates (dashed line) along with the 2.5% and 97.5% simulation quantiles (shaded area) for the case of 2% contamination and
(nD¯, nD) = (200, 200).
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Sample size
(nD¯, nD)
Scenario (100, 100) (200, 200)
No contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 70.0 67.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 71.0 69.0
2% contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 73.0 69.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 72.0 70.0
5% contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 75.0 71.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 73.0 71.0
10% contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 78.0 70.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 75.0 74.0
Table 1: Scenario I. Percentage of time (over the 1000 simulation runs) that the robust AIC favours the robust and flexible model
with no interior knots over the same model but with three interior knots.
Sample size
(nD¯, nD)
Scenario (100, 100) (200, 200)
No contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 71.0 68.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 70.0 68.0
2% contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 73.0 69.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 71.0 70.0
5% contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 75.0 70.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 75.0 69.0
10% contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 80.0 71.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 76.0 72.0
Table 2: Scenario II. Percentage of time (over the 1000 simulation runs) that the robust AIC favours the robust and flexible
model with no interior knots over the same model but with three interior knots.
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Sample size
(nD¯, nD)
Scenario (100, 100) (200, 200)
No contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 72.0 68.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 75.0 68.0
2% contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 72.0 68.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 74.0 70.0
5% contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 75.0 71.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 75.0 71.0
10% contamination
rAICD¯(KD¯1 = 0) < rAICD¯(KD¯1 = 3) 82.0 75.0
rAICD(KD1 = 0) < rAICD(KD1 = 3) 79.0 77.0
Table 3: Scenario III. Percentage of time (over the 1000 simulation runs) that the robust AIC favours the robust and flexible
model with no interior knots over the same model but with three interior knots.
Sample size
(nD¯, nD)
Scenario (100, 100) (200, 200)
No contamination
rAICD¯((KD¯1,KD¯2) = (0, 0)) < rAICD¯((KD¯1,KD¯2) = (3, 3)) 82.0 78.0
rAICD(KD1,KD2) = (0, 0)) < rAICD((KD1,KD2) = (3, 3)) 83.0 78.0
2% contamination
rAICD¯((KD¯1,KD¯2) = (0, 0)) < rAICD¯((KD¯1,KD¯2) = (3, 3)) 85.0 78.0
rAICD(KD1,KD2) = (0, 0)) < rAICD((KD1,KD2) = (3, 3)) 84.0 78.0
5% contamination
rAICD¯((KD¯1,KD¯2) = (0, 0)) < rAICD¯((KD¯1,KD¯2) = (3, 3)) 88.0 82.0
rAICD(KD1,KD2) = (0, 0)) < rAICD((KD1,KD2) = (3, 3)) 87.0 81.0
10% contamination
rAICD¯((KD¯1,KD¯2) = (0, 0)) < rAICD¯((KD¯1,KD¯2) = (3, 3)) 90.0 84.0
rAICD(KD1,KD2) = (0, 0)) < rAICD((KD1,KD2) = (3, 3)) 91.0 86.0
Table 4: Scenario IV. Percentage of time (over the 1000 simulation runs) that the robust AIC favours the robust and flexible
model with no interior knots over the same model but with three interior knots.
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Figure 20: First row: Regression functions resulting from fitting a linear model with a cubic B-splines basis expansion (no interior knots)
for the mean function. Second row: Regression functions resulting from fitting a linear model. Third row: Point estimates from the three
different fits, where the black line is the point estimate from the robust flexible model, the pink line is the point estimate corresponding to
the B-splines linear model and the light green line is the estimate from the linear model. Note that for a better visualization the y axis has
been restricted to the range (10, 100). The shaded areas represent the 95% bootstrap confidence bands (based on 1000 resamples).
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Figure 21: Age-specific AUCs. (a) Estimate resulting from fitting a linear model in each group. (b) Estimate resulting from
fitting a linear model in each group with a cubic B-splines basis expansion for the mean function. (c) Estimate resulting from fitting
the kernel approach in each group. The shaded areas represent the 95% bootstrap confidence bands (based on 1000 resamples).
(d) Comparison of point estimates from the different approaches. Black line: our approach. Light green: linear model. Pink
Line: linear model with B-splines basis expansion for the mean function. Blue line: kernel method. The green and blue line are
indistinguishable.
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